Clinical Trial: A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional

Official Title:

Brief Summary: This is a randomized, double-blind, placebo controlled, multi-center study to evaluate the safety, tolerability and potential effects of dietary supplement Violet™ Iodine on breast health in women with cyclic breast discomfort and tenderness to eliminate the evaluation of effectiveness.

Detailed Summary:
Sponsor: BioPharmX, Inc.

Current Primary Outcome: Change in self assessed cyclic breast discomfort [ Time Frame: After 6 months of active treatment with molecular iodine (I2) compared to placebo ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: BioPharmX, Inc.

Dates:
Date Received: February 3, 2016
Date Started: February 2016
Date Completion:
Last Updated: January 3, 2017
Last Verified: January 2017